Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure (GREARTWAL)

Tongji University

Status

Enrolling

Conditions

Heart Failure

Treatments

Other: Mortality and Rehospitalization rate

Study type

Observational

Funder types

Other

Identifiers

NCT04062500

GREARTWAL

Details and patient eligibility

About

The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.

Full description

Registry for Longitudinal mortality and therapy in patients with Heart Failure is a large, multicenter, prospective, open-label registry of the management of patients treated in the hospital for acute heart failure in China. The objective of this study is to investigate the clinical features and prognosis of patients with heart failure, and discover the characteristics of high-risk heart failure patients, and elucidate critical factors which predict the development and outcomes of symptomatic heart failure patients.

To elucidate the clinical characteristics and prognostic risks of patients with heart failure.
To study the characteristics of high-risk heart failure patients and predict the key factors for the development of symptomatic heart failure patients.
To elucidate the compliance of patients with heart failure and the incidence of adverse drug effects.
To investigate the effect of self-management on outcomes in patients with heart failure.
To elucidate critical factors associated with the development and outcomes of heart failure.
To investigate hospitalization expenses for heart failure.

Enrollment

10,500 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines.

Agree to be tested and sign an informed consent certificate.

Exclusion criteria

1. Age<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.